About C2 Pharma
C2 Pharma is a Healthcare company based in Luxembourg (Luxembourg) founded in 2014 by Andrew Badrot. It manufactures and distributes active pharmaceutical ingredients and compounds worldwide. It operates on a B2B and Wholesale Distribution model in Healthcare and Chemicals & Materials sectors. Its chief executive, as recorded, is Andrew Badrot. Its Indian entity C-Squared Pharma India Private Limited reported revenue of ₹1.51 Cr. C2 Pharma offers products and services including Atropine Sulfate, Bimatoprost, Brimonidine Tartrate, Cyclopentolate Hydrochloride, and Digoxin. Its focus areas include Pharmaceuticals, APIs, Ophthalmic and Niche and Chemical Compounds.
Company details
C2 Pharma is a pharmaceutical group established in 2014 that specializes in manufacturing and distributing active pharmaceutical ingredients and complex chemical compounds from natural and synthetic sources. It operates through a global network, including locations in Ireland, Luxembourg, USA, Germany, and India. The company focuses on ophthalmic and niche APIs, supporting research, development, and supply chain activities for various partners in the pharmaceutical industry.
- Headquarters Luxembourg, Luxembourg
- Founders Andrew Badrot
- SectorsHealthcareChemicals & Materials
- Email••••••••
- Website c2pharma.com
- Legal Name C-Squared Pharma India Private Limited
- Date of Incorporation 09 Apr, 2019
- Jurisdiction Mumbai, Maharashtra, India
- Indian entity revenue₹1.51 Cr
FY 2025 · +56% YoY
- Indian entity net loss-₹16.1 Lakh
FY 2025 · -11% margin
- Indian entity EBITDA-₹14.4 Lakh
FY 2025 · -10% margin
Associated legal entities of C2 Pharma
C2 Pharma operates through C-Squared Pharma India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| C-Squared Pharma India Private Limited CIN U74999MH2019FTC323867 | Active | 09 Apr 2019 | Mumbai, Maharashtra | ₹1.5 Cr | 2 | View details |
Products & Services of C2 Pharma
C2 Pharma offers a comprehensive portfolio of products and services, including Atropine Sulfate, Bimatoprost, Brimonidine Tartrate, Cyclopentolate Hydrochloride, and Digoxin.
Active ingredient used in pharmaceuticals for eye treatments.
Compound for ophthalmic applications in eye care.
Ingredient for glaucoma and ocular hypertension treatments.
Used in eye examinations and dilation procedures.
Cardiac medication for heart failure management.
Enhanced form of digoxin for improved absorption.
Agent for eye dilation in ophthalmic procedures.
Variant for eye care and related applications.
Treatment for reducing intraocular pressure.
Decongestant for nasal and eye relief.
Local anesthetic for eye surgeries.
Medication for glaucoma eye treatment.
Alternative form for eye condition management.
Agent for pupil dilation in eye exams.
Board of directors of C-Squared Pharma India Private Limited (C2 Pharma)
C-Squared Pharma India Private Limited is the primary company behind C2 Pharma. The board of C-Squared Pharma India Private Limited currently have 2 directors; the longest-serving is Andrew Ramsey Badrot, appointed in 2019. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Andrew Ramsey Badrot DIN 08416830 | Director | 09 Apr 2019 | 7 yrs 6 mo | C-Squared Pharma India Private Limited |
| Ragavendran Vasudevan DIN 10102552 | Director | 05 Apr 2023 | 3 yrs 6 mo | C-Squared Pharma India Private Limited |
People of C2 Pharma
11 people are tracked at C2 Pharma (6 in leadership, 5 in team).
| Name | Role | Group |
|---|---|---|
| Founder, CEO | Leadership | |
Ada B. | Director Of Supply Chain And Demand Planning | Leadership |
| Director & Head Operations | Leadership | |
Katrien Oosterom | Senior Vice President Of Regulatory Affairs | Leadership |
Tara Fitzpatrick | Head Of Quality | Leadership |
Loubna Brandenburgerdouhour | Director Of Administration | Leadership |
Francesca Bernardi | Customer Service Manager | Team |
Anastasia Motorina | Regulatory Affairs Manager | Team |
Constanza Maria Paderne | Senior Customer Service Associate | Team |
Eithne OConnor | Senior Quality Assurance Associate | Team |
Helena Sáez Mingorance | Senior Regulatory Affairs Associate | Team |
Complete people profiles for C2 Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of C2 Pharma
Figures of C-Squared Pharma India Private Limited, the primary company behind C2 Pharma, for FY 2025. Revenue was ₹1.51 Cr (+56% year on year). Net loss was -₹16.1 Lakh (-11% margin). EBITDA was -₹14.4 Lakh (-10% margin).
- ₹1.51 CrRevenue · FY 2025 · +56% YoY
- -₹16.1 LakhNet loss · -11% margin
- -₹14.4 LakhEBITDA · -10% margin
- ₹39 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of C-Squared Pharma India Private Limited are on its company page.
Detailed financial statements for C2 Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of C2 Pharma
The website of C2 Pharma (c2pharma.com) receives about 1.4K visits a month.
- Monthly visits1.4K
▼ 29.9% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about C2 Pharma
Complete news archive for C2 Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about C2 Pharma
C2 Pharma was founded in 2014.
C2 Pharma is headquartered in Luxembourg, Luxembourg.
Andrew Badrot is the CEO of C2 Pharma, as recorded in our data. They have also founded this company.
The primary company behind C2 Pharma, C-Squared Pharma India Private Limited, reported revenue of ₹1.51 Cr for FY 2025, up 56% year on year.
C2 Pharma is a pharmaceutical group established in 2014 that specializes in manufacturing and distributing active pharmaceutical ingredients and complex chemical compounds from natural and synthetic sources. It operates through a global network, including locations in Ireland, Luxembourg, USA, Germany, and India. The company focuses on ophthalmic and niche APIs, supporting research, development, and supply chain activities for various partners in the pharmaceutical industry.
C2 Pharma offers Atropine Sulfate, Bimatoprost, Brimonidine Tartrate, Cyclopentolate Hydrochloride, and 6 more products and services.
C2 Pharma operates through C-Squared Pharma India Private Limited.
The legal entities of C2 Pharma currently have 2 directors, including Andrew Ramsey Badrot, Ragavendran Vasudevan.